Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Focus on reteplase: A newly approved third-generation thrombolytic agent for the treatment of acute myocardial infarction

Focus on reteplase: A newly approved third-generation thrombolytic agent for the treatment of acute myocardial infarction. Formulary. 1997; 32:37-45.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.